Evaluation of renal function from 99mTc-MAG3 renography without blood sampling. 1999

Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
Department of Radiology, Institute of Medical Science, University of Tokyo, Japan.

To develop a camera-based method for evaluating renal function with 99mTc-mercaptoacetyltriglycine (MAG3), we examined the relationship between various renogram parameters and 99mTc-MAG3 clearance. METHODS Twenty-one patients underwent renal scintigraphy with 99mTc-MAG3. Eighty 3-s frames were obtained after the bolus injection of 250 MBq tracer, followed by the collection of 52 30-s frames. Regions of interest were drawn for the kidneys, perirenal background areas and subrenal background areas, and background-subtracted renograms were generated. Renal accumulation at 0.5-1.5, 0.5-2, 1-2, 1-2.5 and 1.5-2.5 min after tracer arrival in the kidney was calculated as area under the background-subtracted renogram, and percent renal uptake was obtained after correction for soft-tissue attenuation and injected dose. The slope of the renogram was determined for the same segments used in calculating area under the renogram, and slope index was computed as slope corrected for attenuation and injected dose. Percent renal uptakes and slope indices were correlated by linear regression analysis with 99mTc-MAG3 clearance measured using a single blood sampling method. RESULTS Among the values of percent renal uptake, the value obtained at 1.5-2.5 min using the perirenal background correlated best with 99mTc-MAG3 clearance. The slope index at 0.5-1.5 or 0.5-2 min using the subrenal background provided better accuracy than percent renal uptake for predicting clearance. There were no substantial differences in the relative function of the right kidney between the methods using percent renal uptake and slope index. CONCLUSIONS 99mTc-MAG3 clearance can be assessed with acceptable accuracy by a camera-based method. The method based on the slope of the renogram may replace the one based on the area under the renogram in evaluating renal function from 99mTc-MAG3 renograms.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011866 Radioisotope Renography Graphic tracing over a time period of radioactivity measured externally over the kidneys following intravenous injection of a radionuclide which is taken up and excreted by the kidneys. Renography,Radioisotope Renographies,Renographies,Renographies, Radioisotope,Renography, Radioisotope
D001800 Blood Specimen Collection The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc. Blood Specimen Collections,Collection, Blood Specimen,Collections, Blood Specimen,Specimen Collection, Blood,Specimen Collections, Blood
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016014 Linear Models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression. Linear Regression,Log-Linear Models,Models, Linear,Linear Model,Linear Regressions,Log Linear Models,Log-Linear Model,Model, Linear,Model, Log-Linear,Models, Log-Linear,Regression, Linear,Regressions, Linear
D017263 Technetium Tc 99m Mertiatide A technetium diagnostic aid used in renal function determination. 99mTc-MAG3,Tc 99m Mertiatide,Technetium-99m-MAG3,99mTc-Mercaptoacetyltriglycine,TechneScan MAG3,Technetium 99m Mercaptoacetylglycyl-glycyl-glycine,Technetium-99m-Mercaptoacetylglycylglycylglycine,Technetium-99m-Mercaptoacetyltriglycine,99m Mercaptoacetylglycyl-glycyl-glycine, Technetium,99m Mertiatide, Tc,99mTc MAG3,99mTc Mercaptoacetyltriglycine,MAG3, TechneScan,Mercaptoacetylglycyl-glycyl-glycine, Technetium 99m,Mertiatide, Tc 99m,Technetium 99m MAG3,Technetium 99m Mercaptoacetylglycyl glycyl glycine,Technetium 99m Mercaptoacetylglycylglycylglycine,Technetium 99m Mercaptoacetyltriglycine
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical

Related Publications

Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
December 1997, Kaku igaku. The Japanese journal of nuclear medicine,
Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
January 2022, In vivo (Athens, Greece),
Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
January 2019, Clinical nuclear medicine,
Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
August 2012, Nuclear medicine communications,
Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
January 1999, Kaku igaku. The Japanese journal of nuclear medicine,
Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
April 2012, Clinical nuclear medicine,
Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
September 2020, Diagnostics (Basel, Switzerland),
Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
May 1994, Kaku igaku. The Japanese journal of nuclear medicine,
Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
December 2012, Nuclear medicine communications,
Y Inoue, and T Ohtake, and I Yokoyama, and K Yoshikawa, and S Asai, and K Ohtomo
September 2002, Clinical physiology and functional imaging,
Copied contents to your clipboard!